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ABSTRACT
Overuse of antibio tics contributes to antimicrobial resistance (AMR),
which continues to be a growin g th reat to humanhealth. In theUnited
States, industrial food animal production (IFAP) is a formidable driver
for antibiotic use. Prior work has focused on the lin k betw een
antimicrobial use in poultry and human AMR infectio ns. Common
foodbornepathogens such as Salmonella enterica (S. enterica) along
with Campylo bacter coli (C. coli) and Campylobacter jejuni(C. jejuni)
are commonly associated with humangastroenteritis. However, it has
been shown th at these pathogens are capable of causin g disease
outsid e of thegastrointestin al tract, specificallyurin ary tract infectio ns
(UTIs). Due to th eir ubiquitous natu re on raw and undercooked
poultry, th ese pathogens serve as an overlooked source of UTIs for
indiv iduals with exposure to retail poultry. AMR has become a major
public health concern and predicted to cause more than 10 million
AMR related deaths.
In 2015, California passed senate bill 27 (SB-27), th e fir st bill of its
kind to restrict the use of antimicrobial drugs in the poultry industry.
Implemented on January 1, 2018, th e legislation places poultry
farmers’ ability to admin ister “medically important antimicrobial
drugs” to th eir livestock under th e discretionary supervisio n of
licensed veterinarians. The legislation is intended to reduce antib iotic
usage in the poultry industry for non-th erapeutic purposes such as
preventative measures, promoting weig ht gain , or improving feed
efficiency.
This study, therefore, examin ed the relationship between th e
implementation of SB-27 and rates of AMR in Salmonella and
Campylo bacter species present on retail chickenproduced and sold in
California. Samples were collected weekly from September 2017
through April 2018. Collection sizes ranged from 30-70 samples. S.
enterica, C. coli, and C. jejuni were selected and isolated from th e
meat. Confirmed isolates were then subjected to AMR testing. S.
enterica was found on 15.2 %of samples and Campylobacter spp. on
28.0 %of samples. Resistance was found in14 of15 antibio tics tested
on Salmonella positive samples. Resistance was found on 7 of 7
antibiotics tested on Campylobacter positive samples. In future
analyses, the AMR profiles of th e retail poultry isolates will be
compared to those of clinical isolates from UTI patientsdiagnosed in
proximity to th e outlets from which poultry samples were collected.
This comparison probes the validity of th e foodborne urin ary tract
infection (FUTI)paradigm for Salm onella and Campylo bacter, which
posits the signif icance of foodborne reservoirs of pathogenic bacteria
leading to the acquisitionofurinarytract infection.

METHODS
Our Kais er Permanente col laborators s hipped retail poult ry
collected within the des ignated Southern California
catchment area to our laboratory in Was hington, D.C.

FUTURE WORK

PREPARATORY AND INTERMEDIATE PROCESSING STEPS:
BROTH PREPARATION, SUBSTITUTION, AND FREEZING

CATCHMEN
T AREA
S CIENCE AND
ENGINEERING HALL

We enriched our chicken us ing a multi -s tep, mult i-day
proces s to s elect for Campylobacter s pp. and Salmonella
s pp.

P ictu red : Ad d itio n o f ly sed h o rse
b lo o d to Bo lto n bro th , u sed fo r th e
selectio n o f Ca mp ylo b a cter.

P ictu red : S u b stitu tio n o f b ro ths fo r
seco n d -d ay en rich men t step fo r
selectio n o f S a lmo n ella .

P ictu red : F lash freezin g o f en rich ed
sp ecimen b ro th s.

ISOLATION WORKFLOW

STEP 1: PROCESSING STATION SETUP

P ictu red : Research assistan t
settin g u p rack s an d
au to clav ed b ro th s p rio r to
p ro cessin g .

P ictu red : Research assistan ts h alfway
th ro u g h ty p ical p ro cess. M u ltip le rack s
h av e b een filled with b ro th s an d ch ick en
samp les.

Alali WQ, Thakur S, Berghaus RD, Martin MP, Gebreyes WA:
Prevalence and distribution of Salmonella in organic and
conventional broiler poultry farms. Foodborne pathogens and
disease 2010, 7(11):1363-1371.
Cui S, Ge B, Zheng J, Meng J: Prevalence and antimicrobial
resistance of Campylobacter spp. and Salmonella serovars in
organic chickens from Maryland retail stores. Applied and
environmental microbiology 2005, 71(7):4108-4111.
Luangtongkum T, Morishita TY, Ison AJ, Huang S, McDermott
PF, Zhang Q: Effect of conventional and organic production
practices on the prevalence and antimicrobial resistance of
Campylobacter spp. in poultry. Applied and environmental
microbiology 2006, 72(5):3600-3607.

P ictu red : Research assistan t
p o u rin g Bo lto n b ro ht in ot
samp le to en co u rag e
Ca mp ylo b a cter g ro wth .

RESULTS AND CONCLUSIONS
OBJECTIVES
The objectives:
• To study the pathway of UTI causing bacteria from retail
chicken to humans
• To observe if a decrease in antibiotics used on chickens
results in fewer UTI cases

• Isolates from clinic al and meat samples wil l undergo whole
genome sequencing (WGS) to determine the ir genetic
makeup.
• Sequences from meat samples will be compared to
sequences from clinical samples to hypothesize their
phylo geny and to determine whether clinical UTI cases may
have originated from bacteria present on retail poultry.
• Any links found will further shape the changingparadigm of
how UTIs are contracted and how they might best be trea ted
and prevented from clinical and public health perspectives,
respectively.
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CLINICAL CROSS-REFERENCING
• Our Kaiser Permanente collaborators will be colle cting
clinica l UTI samples from the Southern California
catchment area and send them to us for further testing.
• These samples will undergo isolation processing to test for
the presence of Salmonella and Campylobacter.
• Positive Salmonella and Campylobacter isolat es from
clinica l samples will undergo antibiotic susceptibil ity
testing.

CAMPYLOBACTER
• Campylobacter was isolated from 28.0% (166/523) of
samples.
• Campylobacter was resistant to 3 of 3 antibiotics tested.
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• Salmonella was found on 15.2% (90/592) of samples.
• Salmonella was resistant to 14 of 15 antibiotics tested.
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specimens tested were found to be resistant.
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Table 1. Salmonella Res is tance Rates
Antibiotic
Ampicillin
Amoxicillin/Clavulanic Acid
Azithromycin
Cefoxitin
Ceftiofur
Ceftriaxone
Chloramphenicol
Ciprofloxacin
Gentamicin
Kanamycin
Nalidixic Acid
Streptomycin
Sulfis oxazole
Tetracycline
Trimethoprim-Sulfamethoxazole
*Bas ed on mos t recent year reported

ARAC
45.5%
43.6%
52.8%
30.8%
3.4%
1.9%
34.0%
0.0%
7.2%
2.4%
3.4%
58.8%
45.4%
56.0%
1.4%

NARMS
15.6%
13.1%
--12.2%
12.7%

Antibiotic

ARAC

NARMS*

Ciprofloxacin

15.7%

18.5%

Erythromycin

28.6%

5.0%

Tetracycline

35.2%

44.7%

*Bas ed on mos t recent year reported
0.0%
4.2%
-0.0%
30.8%
27.0%
47.3%
0.4%

Table 3. GW vers us NARM S Recovery Rate
Salmonella

Campylobacter

GW*

90/592 (15.2%)

166/523 (28.0%)

NARMS (2015)

145/2373 (6.1%)

577/2402 (24.0%)

*Bas ed on firs t 592 meat s amples for which complete data are available
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